Fairmount Funds Management’s Astria Therapeutics ATXS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $25.9M | Hold |
|
|||||
|
2025
Q2 | $19.1M | Hold |
|
|||||
|
2025
Q1 | $19M | Hold |
|
|||||
|
2024
Q4 | $31.8M | Hold |
|
|||||
|
2024
Q3 | $39.1M | Hold |
|
|||||
|
2024
Q2 | $32.3M | Hold |
|
|||||
|
2024
Q1 | $50M | Hold |
|
|||||
|
2023
Q4 | $27.3M | Buy |
|
|||||
|
2023
Q3 | $14.2M | Hold |
|
|||||
|
2023
Q2 | $15.8M | Hold |
|
|||||
|
2023
Q1 | $25.3M | Hold |
|
|||||
|
2022
Q4 | $28.3M | Buy |
|
|||||
|
2022
Q3 | $8.24M | Hold |
|
|||||
|
2022
Q2 | $2.73M | Hold |
|
|||||
|
2022
Q1 | $6.12M | Hold |
|
|||||
|
2021
Q4 | $4.91M | Hold |
|
|||||
|
2021
Q3 | $8.06M | Buy |
|
|||||
|
2021
Q2 | $8.63M | Buy |
|
|||||
|
2021
Q1 | $154K | Buy |
|